Abstract | BACKGROUND: Accurate diagnosis of the disease extension of cholangiocarcinoma (CCA) is often difficult in clinical practice. The diagnostic yield of conventional pre-operative imaging or endoscopic procedures is sometimes insufficient for the evaluation of longitudinal spreading of CCA. Here we investigated the usefulness of 5-aminolevulinic acid (5-ALA) for the pre- or intra-operative diagnosis of CCA, using patient-derived organoids. METHODS: Four CCA- and two adjacent tissue-derived organoids were established. After 5-ALA treatment, we assessed their photodynamic activity using fluorescence microscopy. RESULTS: CCA organoids established from different patients showed diverse morphology in contrast to monolayer structures of non- tumor organoids, and had the ability to form subcutaneous tumors in immunodeficient mice. CCA organoids demonstrated remarkably high photodynamic activity based on higher accumulation of protoporphyrin IX as a metabolite of 5-ALA compared to non- tumor organoids (40-71% vs. < 4%, respectively). Importantly, cancer cell-specific high photodynamic activity distinguished the organoids originated from biliary stenotic lesions from those of non-stenotic lesions in a CCA patient. The high photodynamic activity did not depend on the expression profile of heme biosynthesis genes. CONCLUSIONS: Distinct 5-ALA-based photodynamic activity could have diagnostic potential for the discrimination of CCA from non- tumor tissues.
|
Authors | Hiroaki Fujiwara, Naminatsu Takahara, Keisuke Tateishi, Mariko Tanaka, Sachiko Kanai, Hiroyuki Kato, Takuma Nakatsuka, Keisuke Yamamoto, Hirofumi Kogure, Junichi Arita, Yousuke Nakai, Masato Kasuga, Tetsuo Ushiku, Kiyoshi Hasegawa, Kazuhiko Koike |
Journal | Surgical oncology
(Surg Oncol)
Vol. 35
Pg. 484-490
(Dec 2020)
ISSN: 1879-3320 [Electronic] Netherlands |
PMID | 33126085
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- Levulinic Acids
- Protoporphyrins
- protoporphyrin IX
|
Topics |
- Aged
- Aged, 80 and over
- Animals
- Bile Duct Neoplasms
(drug therapy, metabolism, pathology)
- Cholangiocarcinoma
(drug therapy, metabolism, pathology)
- Female
- Follow-Up Studies
- Humans
- Levulinic Acids
(pharmacology)
- Male
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Middle Aged
- Organoids
(drug effects, metabolism, pathology)
- Photochemotherapy
(methods)
- Prognosis
- Protoporphyrins
(analysis, metabolism)
- Xenograft Model Antitumor Assays
- Aminolevulinic Acid
|